---
title: "Kalaris Therapeutics (KLRS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KLRS.US/norm.md"
symbol: "KLRS.US"
name: "Kalaris Therapeutics"
parent: "https://longbridge.com/en/quote/KLRS.US.md"
datetime: "2026-03-04T13:07:11.869Z"
locales:
  - [en](https://longbridge.com/en/quote/KLRS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KLRS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KLRS.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/KLRS.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/KLRS.US/norm.md)


# Kalaris Therapeutics (KLRS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.6360 | -0.6069 | -2.52 | -3.28 | -28.16 |
| ROE | -100.18% | -77.61% | 249.12% | - | - |
| Revenue | - | - | - | - | - |
| Net income | -11.89M | -11.35M | -10.20M | -22.03M | -38.08M |
| Operating income | -12.74M | -12.26M | -10.35M | -7.13M | -37.85M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 81.17M | 92.84M | 103.09M | 6.16M | 2.46M |
| Leverage | 1.94 | 1.75 | 1.61 | -0.1217 | -0.0567 |
| BVPS | 2.24 | 2.84 | 3.42 | -14.36 | -13.32 |
| Turnover | - | - | - | - | - |
| Cash & STI | 77.00M | 88.43M | 100.97M | 1.64M | 1.91M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 1.52M | - | - | - | - |
| Net debt | -75.45M | -88.43M | -100.97M | 18.27M | 7.34M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -11.33M | -12.54M | -7.44M | -7.85M | -4.33M |
| Investing CF | -34.71M | - | - | - | - |
| Financing CF | 0.0000 | 0.0000 | 107.27M | 7.58M | 1000.00 |
| Free CF | -7.43M | -8.57M | -4.00M | - | - |
| OCF coverage | -6192.90% | - | - | - | - |
| Repaid & issued | 0.0000 | 0.0000 | 7.50M | 9.97M | 0.0000 |
| CapEx | -183000.00 | - | - | - | - |